Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution

Core Viewpoint - ESSA Pharma Inc. announced a return of capital distribution totaling US$80 million to its shareholders as part of its winding-up process following a transaction with XenoTherapeutics, Inc. [1] Group 1: Distribution Details - The distribution amount per common share is approximately $1.6910318, paid on August 22, 2025 [1] - The ex-dividend date for the distribution is set for August 25, 2025, which is the first business day after the payment date [1] - The Due Bill Period was incorrectly stated in a previous press release; the correct period is from August 19, 2025, to August 22, 2025 [2] Group 2: Company Background - ESSA Pharma Inc. is a pharmaceutical company that previously focused on developing therapies for prostate cancer [3]